PACB

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Dollar change -0.09
Percentage change -4.16	%

Peers: ILMN GH TXG CRSP QGEN TWST CDNA FLGT BGNE FATE

| Held by: ARKK ARKG VTI IWM VXF IWN IBB VTWO SCHA VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.46	Insider Own	11.70%	Shs Outstand	273.81M	Perf Week	-3.45%
Market Cap	536.77M	Forward P/E	-	EPS next Y	-0.69	Insider Trans	-0.57%	Shs Float	241.81M	Perf Month	-1.01%
Income	-394.24M	PEG	-	EPS next Q	-0.20	Inst Own	83.15%	Short Float	22.49%	Perf Quarter	5.95%
Sales	173.15M	P/S	3.10	EPS this Y	-12.49%	Inst Trans	22.41%	Short Ratio	5.61	Perf Half Y	11.36%
Book/sh	1.65	P/B	1.18	EPS next Y	49.56%	ROA	-23.55%	Short Interest	54.38M	Perf Year	-77.88%
Cash/sh	1.72	P/C	1.14	EPS next 5Y	-1.00%	ROE	-64.80%	52W Range	1.16 - 10.65	Perf YTD	-80.02%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-9.76%	ROI	-28.92%	52W High	-81.60%	Beta	1.95
Dividend TTM	-	Quick Ratio	8.64	Sales past 5Y	24.48%	Gross Margin	5.55%	52W Low	68.97%	ATR (14)	0.22
Dividend Ex-Date	-	Current Ratio	9.74	EPS Y/Y TTM	-13.90%	Oper. Margin	-166.70%	RSI (14)	48.59	Volatility	11.46% 11.02%
Employees	796	Debt/Eq	2.03	Sales Y/Y TTM	2.14%	Profit Margin	-227.69%	Recom	2.19	Target Price	2.87
Option/Short	Yes / Yes	LT Debt/Eq	2.01	EPS Q/Q	15.14%	Payout	-	Rel Volume	1.03	Prev Close	2.05
Sales Surprise	-4.73%	EPS Surprise	0.32%	Sales Q/Q	-28.23%	Earnings	Nov 07 AMC	Avg Volume	9.70M	Price	1.96
SMA20	2.86%	SMA50	-0.97%	SMA200	-6.08%	Trades		Volume	10,000,452	Change	-4.16%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-11-24	Downgrade	UBS	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Buy	$4
Apr-22-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-18-24	Downgrade	Goldman	Buy → Neutral	$7 → $2.50
Dec-14-23	Initiated	Stephens	Overweight	$11
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-17-23	Upgrade	UBS	Neutral → Buy	$13 → $10
Oct-31-23	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$11
Sep-28-23	Initiated	Bernstein	Outperform	$11
Jul-05-23	Resumed	JP Morgan	Overweight	$13
Jun-30-23	Initiated	Goldman	Buy	$17
May-10-23	Initiated	Barclays	Equal Weight	$14
Mar-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $15
Feb-02-23	Initiated	UBS	Neutral	$13
Jan-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$12
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$12
Jan-21-22	Resumed	Cantor Fitzgerald	Overweight	$62 → $31
Jan-06-22	Resumed	Piper Sandler	Neutral	$20
Oct-15-21	Resumed	Cowen	Market Perform	$30

Show Previous Ratings

Dec-11-24 11:50AM	Why Pacific Biosciences of California (PACB) Is the Worst ARK Stock to Buy According to Short Sellers (Insider Monkey)
Nov-19-24 07:01PM	Pacific Biosciences of California, Inc. (PACB): Among the Best Genomics Stocks to Buy Right Now (Insider Monkey) +9.55%
Nov-12-24 11:55AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool) -10.37%
Nov-08-24 04:05PM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) -6.12% +6.96%
06:03AM	Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Call Highlights: Navigating ... (GuruFocus.com)
07:30PM	Loading…
Nov-07-24 07:30PM	Pacific Biosciences (PACB) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -7.55%
06:15PM	Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
05:14PM	Pacific Biosciences: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Third Quarter 2024 Financial Results (GlobeNewswire)
04:03PM	PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028 (GlobeNewswire)
Nov-06-24 10:35PM	PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop (GlobeNewswire)
07:30AM	Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-04-24 09:16AM	Curious about Pacific Biosciences (PACB) Q3 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
Oct-31-24 06:15PM	Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors (Zacks) +12.44%
Oct-30-24 02:57PM	Pacific Biosciences (PACB): Promising Gene Editing Stock With Innovating Technology (Insider Monkey)
10:13AM	Loading…
10:13AM	Volta Labs joins PacBio Compatible program to help PacBio customers scale sequencing through automated library prep (PR Newswire)
Oct-29-24 09:05AM	PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to less than $500 (GlobeNewswire) +11.96%
Oct-22-24 09:05AM	PacBio Onso Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program (GlobeNewswire)
Oct-16-24 06:15PM	Pacific Biosciences of California (PACB) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks) -7.77%
Oct-11-24 09:05AM	PacBio Enters Cancer Genomics Research Collaboration in Singapore with Advanced Onso Sequencing (GlobeNewswire) +27.74%
Oct-10-24 04:05PM	PacBio to Report Third Quarter 2024 Financial Results on November 7, 2024 (GlobeNewswire)
Oct-01-24 09:05AM	PacBio, A*STAR, and Macrogen Unveil State-of-the-Art Lab to Accelerate Genomics Innovation in Singapore (GlobeNewswire)
Sep-27-24 06:15PM	Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors (Zacks)
04:05PM	PacBio Grants Equity Incentive Award to New Employee (GlobeNewswire)
Sep-13-24 06:15PM	Pacific Biosciences of California (PACB) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
Sep-11-24 12:38PM	Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now (Zacks)
09:05AM	PacBio Announces the HiFi Solves Sub-fertility Consortium in Asia Pacific (GlobeNewswire)
Sep-08-24 04:51PM	Pacific Biosciences of California, Inc. (PACB): Among the Worst ARK Stocks According to Short Sellers (Insider Monkey)
11:49AM	10 Worst ARK Stocks To Buy According To Short Sellers (Insider Monkey)
Sep-04-24 09:05AM	Revio to Power Research in Male Infertility and Rare Disease at Munster University Hospital (GlobeNewswire)
09:05AM	Loading…
09:05AM	Revio to Power Research in Male Infertility and Rare Disease at M nster University Hospital (GlobeNewswire)
Aug-26-24 04:03PM	PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire) -8.13%
Aug-12-24 12:00PM	Pacific Biosciences (PACB) Upgraded to Buy: Here's Why (Zacks) -10.06%
Aug-08-24 12:09PM	PacBio (PACB) Q2 Earnings Beat Estimates, Revenues Down Y/Y (Zacks) +9.15%
Aug-07-24 07:30PM	Compared to Estimates, Pacific Biosciences (PACB) Q2 Earnings: A Look at Key Metrics (Zacks)
07:15PM	Pacific Biosciences of California (PACB) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
06:10PM	Pacific Biosciences: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Second Quarter 2024 Financial Results (GlobeNewswire)
10:24AM	Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now (Zacks)
Aug-05-24 04:05PM	Singapore's National Precision Medicine (NPM) programme will partner with PacBio to propel HiFi Sequencing in Southeast Asia (GlobeNewswire) -7.49%
Jul-31-24 04:29AM	Why Is Pacific Biosciences of California, Inc. (PACB) the Best Micro Cap Stocks According to Hedge Funds? (Insider Monkey)
Jul-30-24 06:15PM	Pacific Biosciences of California (PACB) Flat As Market Sinks: What You Should Know (Zacks)
Jul-24-24 06:15PM	Pacific Biosciences of California (PACB) Ascends While Market Falls: Some Facts to Note (Zacks)
09:56AM	PacBio's (PACB) Revio System to Boost Novogene's German Lab (Zacks)
Jul-23-24 09:05AM	Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing (GlobeNewswire)
Jul-15-24 04:03PM	PacBio to Report Second Quarter 2024 Financial Results on August 7, 2024 (GlobeNewswire) +34.26%
Jul-02-24 11:56AM	Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now (Zacks) +6.67%
Jul-01-24 10:26AM	PacBio (PACB) and Form Bio to Boost AAV Industry Development (Zacks) -12.41%
Jun-28-24 06:15PM	Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors (Zacks)
Jun-27-24 10:09AM	Pacific Biosciences of California, Inc (PACB): A Good Buy According to Analysts? (Insider Monkey)
09:00AM	Form Bio and PacBio Announce Collaboration to Launch New Resources Set to Transform AAV Design and Analysis Best Practices (ACCESSWIRE)
Jun-26-24 04:36PM	Top 10 Small-Cap Stocks with Highest Upside Potential (Insider Monkey)
Jun-18-24 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jun-13-24 10:12AM	Jefferies Says Buy These 3 Stocks for More Than Double-Digit Returns (InvestorPlace) -6.57%
Jun-10-24 09:05AM	PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database (PR Newswire) -5.97%
May-29-24 01:00PM	Reasons to Retain PacBio (PACB) Stock in Your Portfolio (Zacks)
May-27-24 08:00AM	Why Cathie Wood Thinks Stock Fears Are At 'Depression' Levels (Investor's Business Daily)
May-23-24 09:00AM	Pacific Biosciences of California, Inc. (PACB) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
May-15-24 11:53AM	Pacific Biosciences, Ambry Genetics Selected to Sequence up to 7,000 Human Genomes (MT Newswires)
10:48AM	Morgan Stanley Adjusts Price Target on Pacific Biosciences of California to $4 From $10, Maintains Equal-Weight Rating (MT Newswires)
09:45AM	Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases (PR Newswire)
May-14-24 03:46AM	Pacific Biosciences to lay off 195 employees as part of cost cuts (MedTech Dive) +15.54%
May-13-24 09:47AM	Piper Sandler Adjusts Price Target on Pacific Biosciences of California to $2 From $6.50, Maintains Neutral Rating (MT Newswires) +9.04%
May-10-24 06:32PM	Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2024 Earnings Call Transcript (Insider Monkey)
02:43PM	Pacific Biosciences of California Inc (PACB) Q1 2024 Earnings: Narrowing Losses but Misses ... (GuruFocus.com)
11:16AM	PacBio (PACB) Q1 Earnings In Line, Adjusted Gross Margin Up (Zacks)
May-09-24 08:55PM	PACB Stock Earnings: Pacific Biosciences Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:30PM	Pacific Biosciences (PACB) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
06:10PM	Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:04PM	Pacific Biosciences: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces First Quarter 2024 Financial Results (PR Newswire)
May-07-24 12:12PM	Soft Instrument Orders Likely to Hurt PacBio's (PACB) Q1 Earnings (Zacks) -6.03%
May-02-24 09:00AM	Investors Heavily Search Pacific Biosciences of California, Inc. (PACB): Here is What You Need to Know (Zacks)
Apr-25-24 09:35AM	Here's Why Pacific Biosciences (PACB) is Poised for a Turnaround After Losing -63.44% in 4 Weeks (Zacks)
Apr-23-24 12:00PM	Pacific Biosciences (PACB) Upgraded to Buy: Here's What You Should Know (Zacks) -5.77%
Apr-17-24 01:00PM	PacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase Delays (Zacks)
Apr-16-24 02:47PM	The Cathie Wood Stock Shuffle: 4 Names Shes Loving, 3 Shes Leaving (InvestorPlace) -50.62%
08:05AM	PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance (PR Newswire)
Apr-03-24 10:54AM	Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now (Zacks)
Mar-27-24 08:00AM	Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes (PR Newswire) +5.68%
Mar-22-24 04:30PM	PacBio Grants Equity Incentive Award to New Employee (PR Newswire)
Mar-13-24 03:32PM	11 Oversold NASDAQ Stocks To Buy Right Now (Insider Monkey) +5.74%
10:17AM	PacBio's (PACB) New Panel to Aid Its Clinical Research Solution (Zacks)
Mar-12-24 09:05AM	PacBio Announces PureTarget Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions (PR Newswire) -8.86%
Mar-06-24 11:57PM	Director David Meline Acquires 40,000 Shares of Pacific Biosciences of California Inc (PACB) (GuruFocus.com) +9.94%
Feb-27-24 03:30AM	12 Best Medical Stocks to Buy Under $10 (Insider Monkey) +7.46%
Feb-26-24 04:05PM	PacBio to Present at Upcoming Investor Conferences (PR Newswire)
Feb-25-24 07:04AM	14 Best Beaten Down Stocks To Buy Right Now (Insider Monkey)
Feb-22-24 04:21AM	13 Best Falling Stocks To Buy Right Now (Insider Monkey)
Feb-16-24 10:50AM	PacBio (PACB) Q4 Earnings Beat, Adjusted Gross Margin Down (Zacks) -13.94%
08:59AM	Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:34AM	Q4 2023 Pacific Biosciences of California Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-15-24 06:30PM	Pacific Biosciences (PACB) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:30PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:43PM	Pacific Biosciences of California Inc (PACB) Reports Substantial Revenue Growth Amidst Widening ... (GuruFocus.com)
04:28PM	Pacific Biosciences: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results (PR Newswire)
Feb-13-24 07:00AM	Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product Launch (PR Newswire) -9.39%
Feb-10-24 05:09PM	Top 11 CRISPR Stocks To Invest In (Insider Monkey)
Feb-06-24 09:41AM	PacBio's (PACB) New Kits to Boost Its Revio Sequencing System (Zacks)

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kim Susan G.	See Remarks	Sep 30 '24	Sale	1.72	19,782	34,065	695,654	Oct 02 04:13 PM
SUSAN KIM	Officer	Sep 30 '24	Proposed Sale	1.72	19,782	34,061		Sep 30 04:03 PM
HENRY CHRISTIAN O	See Remarks	Sep 16 '24	Sale	1.75	98,907	172,692	2,497,763	Sep 17 04:11 PM
CHRISTIAN HENRY	Officer	Sep 16 '24	Proposed Sale	1.75	98,907	172,741		Sep 16 05:40 PM
Eidel Jeff	See Remarks	Aug 19 '24	Sale	1.59	26,760	42,602	869,730	Aug 20 05:27 PM
Van Oene Mark	See Remarks	Aug 16 '24	Sale	1.66	38,011	63,174	1,630,815	Aug 20 05:25 PM
JEFFREY EIDEL	Officer	Aug 19 '24	Proposed Sale	1.59	26,760	42,589		Aug 19 04:24 PM
MARK VAN OENE	Officer	Aug 16 '24	Proposed Sale	1.66	38,011	63,189		Aug 16 04:29 PM
Farmer Michele	See Remarks	May 20 '24	Sale	2.03	5,275	10,708	211,941	May 22 05:25 PM
ORDONEZ KATHY	Director	Mar 15 '24	Option Exercise	2.87	361,621	1,038,682	380,216	Mar 19 04:24 PM
Meline David W	Director	Mar 06 '24	Buy	4.40	40,000	176,160	40,000	Mar 06 05:36 PM
Farmer Michele	See Remarks	Mar 04 '24	Sale	4.87	2,968	14,457	217,216	Mar 06 05:30 PM
Van Oene Mark	See Remarks	Mar 04 '24	Sale	4.87	9,186	44,745	1,668,826	Mar 06 05:26 PM
Kim Susan G.	See Remarks	Mar 04 '24	Sale	4.87	5,275	25,695	712,260	Mar 06 05:22 PM
HENRY CHRISTIAN O	See Remarks	Mar 04 '24	Sale	4.87	14,177	69,056	2,596,670	Mar 06 05:12 PM
MOHR MARSHALL	Director	Mar 01 '24	Option Exercise	4.45	25,000	111,250	110,000	Mar 05 04:27 PM
Van Oene Mark	See Remarks	Feb 16 '24	Sale	5.96	33,560	199,950	876,611	Feb 21 06:25 PM
Eidel Jeff	See Remarks	Feb 16 '24	Sale	5.96	15,498	92,337	431,824	Feb 21 06:20 PM
Kim Susan G.	See Remarks	Feb 16 '24	Sale	5.96	22,496	134,031	283,589	Feb 21 06:17 PM
Kim Susan G.	See Remarks	Feb 20 '24	Sale	5.26	831	4,372	282,758	Feb 21 06:17 PM
HENRY CHRISTIAN O	See Remarks	Feb 16 '24	Sale	5.96	79,038	470,908	1,007,057	Feb 21 06:14 PM
HENRY CHRISTIAN O	See Remarks	Feb 20 '24	Sale	5.26	1,979	10,412	1,005,078	Feb 21 06:14 PM
Farmer Michele	See Remarks	Feb 16 '24	Sale	5.96	7,562	45,054	101,164	Feb 21 06:07 PM
Van Oene Mark	See Remarks	Jan 09 '24	Sale	7.77	31,012	241,056	910,171	Jan 10 05:44 PM
HENRY CHRISTIAN O	See Remarks	Dec 14 '23	Sale	10.00	20,000	200,000	1,086,095	Dec 15 04:35 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Pacific Biosciences of California Inc

Upgrade your FINVIZ experience